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ST]MMARY
The possibility to manufacture large quantities of monoclonal
antibodies has opened new fields in lymphoma research and diagnostic
pathology. In this thesis the results of the study of the immunological
profile, morphology and in part clinical behavior of a large series of non
Hodgkin's lymphomas are presented.
chapter 1 describes the development of so called paraffin reactive
monoclonal antibodies. The development of such antibodies is of great
importance since they combine good morphological detail and
immunohistochemical staining. The antibodies MTl , MTz, MBl, MB2
and MB3 were biochemically characterized and tested against normal
lymphoid tissue, a series of non Hodgkin's lymphomas and non lymphoid
tissues. Antibody MTI is reactive with mature and immature T cells and
not with mature B cells. MT2 is reactive with mature T cells and B cells,
but not with immature T cells, activated T cells, and germinal center B
cells. Antibody MBl is reactive with all b cells, with about 50% of
mature T cells, and not with immature T cells. MB2 is reactive with all B
cells and not with T cells. However, MB2 also stains endothelial cells and
several types of epithelial cells. MB3 is reactive with B cells and
histiocytes, but not with T cells.
Chapter 2 describes the study of centroblastic centrocytic and
centrocytic lymphomas. It was demonstrated that despite morphological
mimicry the centrocytes of centroblastic entrocytic lymphoma and those
of centrocytic lymphoma are different. The immunophenotypes of
centrocytic lymphoma (IgM/IgD, MTI positive and CALLA negative)
indicate a mantle zone or very early follicle center derivation whereas the
immunophenotype of the centrocytes of centroblastic centrocytic
lymphoma (IgM, or IgG/IgA, CALLA positive and MTI negative)
indicate a true follicle center derivation.
Chapter 3 describes the study of lymphocytic lymphomas
presenting with lymphadenopathy (group A cases) and those presenting
with splenomegaly (group B cases). It was assumed that the known
diversity of the small lymphocytes in the mantle zone of germinal centers
might reflect itself in the lymphomas that are presumably derived from
these cells. Lymphocytic lymphomas of group A were predominantly
CD5, CD1lc, CD23 and CD43 positive resembling the major
compartment of small B lymphocytes as found in the mantle zone and
peripheral blood as opposed to the group B cases which were
predominantly CD5, CDllc, CD23 and CD43 negative. Lymphocytic
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lymphomas with a mantle zone growth pattern without proliferation
centers were CD45RO and alkaline phosphatase positive.
Chapter 4 describes the study of large cell B cell lymphomas with
focus upon the centroblastic lymphomas. The clinical relevancy of a
recently proposed morphological subclassification of these lymphomas
was demonstrated. Immunophenotyping did not discriminate between the
subcategories of centroblastic lymphoma. The absence in the majority of
cases of rearrangement of the gene coding for Bcl2 and the aberrant
immunophenotypes of the large cell lymphomas support the assumption
that tumorprogression plays a role in the genesis of the large cell
lymphomas. Tumorprogression not necessarily follows normal B cell
differentiation and therefore these lymphomas may not reflect true frozen
states of normal B cell differentiation.
Chapter 5 describes the morphology and immunophenotypes of T
cell lymphomas. The lymphomas \vere subclassified according to the
recently proposed updated Kiel classification. The expression of CD1 and
the concomitant expression of CD4 and CD8 are characteristic for the
lymphoblastic lymphomas. Their immunophenotypes can be related to
normal intrathymic differentiation stages. It was also in this group that we
found the so called aberrant expression of dual expression of pan B and
pan T cell markers. The small cell peripheral T cell lymphomas usually
do have a complete immunophenotype matching that of normal peripheral
T cells. Loss of pan T cell markers is a coÍnmon phenomenon with the
large cell T cell lymphomas and may serve as a diagnostic criterion.
Chapter 6 describes a case of Sjógrens Syndrome with involvement
of the lymphnodes and skin. The patient developed morphological atypical
clonal T cell infiltrates in the skin which were interpreted as a peripheral
T cell lymphoma. The infrltrates in the submandibular lymphnode and the
parotid gland showed the same clonal T cell receptor rearrangement.
Apart from the well known risk of the development of a B cell lymphoma
in Sjógrens Syndrome the risk of the development of a T cell lymphoma
must therefore be taken into account.
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